cancer inhibitors trang 13 tải miễn phí từ TAILIEUCHUNG

"cancer inhibitors" trang 13 - tải miễn phí từ Tailieuchung

The epigenetic immunomodulator, HBI8000, enhances the response and reverses resistance to checkpoint inhibitors

The epigenetic immunomodulator, HBI8000, enhances the response and reverses resistance to checkpoint inhibitors

17 50 1

Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis

Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis

9 48 1

Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review

Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review

7 16 1

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

8 9 1

Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: A single center experience and literature review

Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: A single center experience and literature review

11 8 1

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor

8 8 1

Breast Cancer: Prognosis, Treatment, and Prevention Second Edition

Breast Cancer: Prognosis, Treatment, and Prevention Second Edition

609 43 0

Progesterone receptor modulators in breast cancer

Progesterone receptor modulators in breast cancer

14 96 0

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer

10 71 0

Sirtuin1 activator SRT2183 suppresses glioma cell growth involving activation of endoplasmic reticulum stress pathway

Sirtuin1 activator SRT2183 suppresses glioma cell growth involving activation of endoplasmic reticulum stress pathway

11 53 0

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: Predictors and pitfalls

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: Predictors and pitfalls

8 54 0

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

17 72 0

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

10 31 1

Early onset recall pneumonitis during targeted therapy with sunitinib

Early onset recall pneumonitis during targeted therapy with sunitinib

4 20 1

EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

8 26 1

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations

8 14 1

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report

5 51 1

Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment

Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment

7 19 1

Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: A case report

Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: A case report

4 70 0

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

4 51 0

Đầu
1
2
3
4
5
6
7
8
9
10
11
12
[ 13 ]
14
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.